This cohort study investigates the outcomes of sodium-glucose cotransporter-2 inhibitor (SGLT-2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy among patients with type 2 diabetes in South Korea, by the presence or absence of nonalcoholic fatty liver disease (NAFLD).
Recent Posts
- Psychological Mechanisms of Narrative Transportation on Brand Outcomes: A Higher Order Brand Experience Model and Product Type Boundary Conditions
- Negotiating Academic Identity in Dilemmatic Space: An Identity Trajectory of an Early-Career Academic in a Marginal Discipline
- JAMA+ Trials Editor’s Choice for Clinical Trial of 2025 in JAMA Network Open
- Patterns of Outpatient Psychotherapy Among Children With Insurance
- Monitoring Changes in Clinical Trial Primary Outcomes Using Large Language Models